LGC Axolabs specialises in a new class of treatments whose active ingredients are chemically derived from DNA or RNA. They are called oligonucleotide or nucleic acid therapeutics.
We use our many years of expertise to help our clients make them a success. Some of these treatments have already been approved and are being used successfully against diseases that were previously untreatable in some cases. New treatments from this class are added every year.
Our broad range of services for therapeutic oligonucleotides and mRNAs includes bioinformatics, chemical synthesis of oligonucleotides, oligonucleotide conjugates and formulations, analytics, bioanalytics and in vitro testing.